Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ten-eleven translocation family proteins are key epigenetic regulators responsible for dynamic changes in cytosine methylation status via oxidation reactions. They influence development, immune response modulation, stem cell biology, brain function, tumor suppression/promotion depending on context—and represent important targets for research into diagnostics and therapeutics across multiple disease areas.
Catalyzes the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC). These oxidized cytosines are intermediates in DNA demethylation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ten-eleven Translocation Family Proteins (TET).